| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/20/2011 | CN101194960B Oral liquid for treating headache and method for preparing the same |
| 07/20/2011 | CN101177427B Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 07/20/2011 | CN101129384B Method for preparing carbamazepine sustained-release capsules |
| 07/20/2011 | CN101113172B Anti-opium peptide and antagonistic peptide and its application |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982048 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 07/19/2011 | US7982038 Ligands |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981906 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981884 Process for the preparation of olanzapine |
| 07/19/2011 | US7981882 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 07/19/2011 | US7981863 Administering platelet derived growth factor, endothelial growth factor or a combination to modulate neural stem cell or neural porgenitor cell activity in vivo to a patient suffering from nerveous system disorder or disease |
| 07/19/2011 | US7981433 Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2578626C Modified-release formulations of a bupropion salt |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2465691C 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
| 07/19/2011 | CA2463300C Thiopene- and thiazolesulfonamides as antineoplastic agents |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2432464C Excitatory amino acid receptor antagonists |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2417388C Therapeutic polyanhydride compounds for drug delivery |
| 07/19/2011 | CA2398747C Herbal supplement containing galanthamine for treating symptoms of estrogen-deficiency |
| 07/19/2011 | CA2380920C Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 07/19/2011 | CA2341441C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 07/19/2011 | CA2321900C Agents with serotonin-related activity for the treatment for sleep apnea |
| 07/14/2011 | WO2011085351A2 Method of treating kcnq related disorders |
| 07/14/2011 | WO2011085291A1 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors |
| 07/14/2011 | WO2011085216A2 Use of faah inhibitors for treating parkinson's disease and restless legs syndrome |
| 07/14/2011 | WO2011085162A2 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
| 07/14/2011 | WO2011084642A1 Compound suitable for the treatment of synucleopathies |
| 07/14/2011 | WO2011084620A2 Particles for multiple agent delivery |
| 07/14/2011 | WO2011084437A1 Mglu2 agonists |
| 07/14/2011 | WO2011084434A2 Aza-ring fused indole and indoline derivatives |
| 07/14/2011 | WO2011084433A2 Aza-bridged ring-fused indoles and indolines |
| 07/14/2011 | WO2011084025A2 Hexane extract |
| 07/14/2011 | WO2011083881A1 Vaccine for treatment of tautopathy |
| 07/14/2011 | WO2011083827A1 Cerebral nerve cell neogenesis agent |
| 07/14/2011 | WO2011083823A1 Prophylactic or therapeutic agent for schizophrenia |
| 07/14/2011 | WO2011083487A1 Sulfone compounds as 5-ht6 receptor ligands |
| 07/14/2011 | WO2011083316A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | WO2011083315A1 Compounds and their use |
| 07/14/2011 | WO2011083314A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | WO2011083304A1 Prodrugs of opioids and uses thereof |
| 07/14/2011 | WO2011083278A1 Novel benzoic pyrrolopyridine derivatives |
| 07/14/2011 | WO2011083265A1 Novel derivatives of cyclopropylated benzothiadiazines, method for preparing same and pharmaceutical compositions containing same |
| 07/14/2011 | WO2011083264A1 Thiochroman derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/14/2011 | WO2011082617A1 (e)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene and preparation method and use thereof |
| 07/14/2011 | WO2011082565A1 Artificial nerve graft with neurotrophic factor fixed by genipin and preparation method thereof |
| 07/14/2011 | WO2011061700A3 Ifnϒ inhibitors in the treatment of motoneuron diseases |
| 07/14/2011 | WO2011054001A8 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 07/14/2011 | WO2011035212A3 Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury |
| 07/14/2011 | WO2011030224A3 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
| 07/14/2011 | WO2011026060A9 Treatment and prevention of secondary injury after trauma or damage to the central nervous system |
| 07/14/2011 | WO2011026051A3 Tea based smoking product |
| 07/14/2011 | WO2011025230A3 Gaba release-regulating agent in cerebellum |
| 07/14/2011 | WO2011022292A3 Method of treating bipolar disorder or depression using an antiestrogen |
| 07/14/2011 | WO2011021832A3 Composition for preventing or treating a spinal cord injury |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172312 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| 07/14/2011 | US20110172310 Di-fluoro containing compounds as cysteine protease inhibitors |
| 07/14/2011 | US20110172306 Creatine ester pronutrient compounds and formulations |
| 07/14/2011 | US20110172305 Endocannabinoids for Enhancing Growth and Development in Infants |
| 07/14/2011 | US20110172297 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172291 Rna interference for the treatment of gain-of-function disorders |
| 07/14/2011 | US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 07/14/2011 | US20110172286 Cd44 splice variants in neurodegenerative diseases |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172283 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators |
| 07/14/2011 | US20110172280 Substituted Benzimidazoles |
| 07/14/2011 | US20110172274 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 07/14/2011 | US20110172272 Benzisoxazoles |
| 07/14/2011 | US20110172270 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 07/14/2011 | US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/14/2011 | US20110172264 Nicotinic acetylcholine receptor modulators |
| 07/14/2011 | US20110172262 Compositions and methods for treating epilepsy |
| 07/14/2011 | US20110172260 Methods of providing weight loss therapy in patients with major depression |
| 07/14/2011 | US20110172259 Dosage form containing oxycodone and naloxone |
| 07/14/2011 | US20110172255 Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists |
| 07/14/2011 | US20110172252 Triazolo[4,5-d]pyramidine derivatives and their use as purine receptor antagonists |
| 07/14/2011 | US20110172251 Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| 07/14/2011 | US20110172248 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/14/2011 | US20110172247 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/14/2011 | US20110172246 1-(2-phenoxymethylphenyl)piperazine compounds |
| 07/14/2011 | US20110172240 Fatty acid fumarate derivatives and their uses |
| 07/14/2011 | US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease |
| 07/14/2011 | US20110172236 Substituted aryl sulfone derivatives as calcium channel blockers |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172229 Modulators of atp-binding cassette transporters |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |